Associate Professor Herrero is a scientifically and medically trained NHMRC Research Fellow studying the glycobiology of vector-borne diseases. Her research is primarily focused on deciphering the mechanisms behind alphavirus-induced arthritis and arthralgia and aims to translate basic science into clinical outcomes. Associate Professor Herrero has examined the pathobiology of emerging mosquito-borne viruses such as chikungunya, dengue, Ross River and Barmah Forest viruses and has developed a novel therapeutic for Ross River-induced arthritis which has successfully passed phase II clinical trials.